American Diabetes Association demands review of incretin-based medicines linked to pancreatic cancer
Will pay $2.15bn in landmark patent infringement lawsuit
Outlines thinking on non-clinical and clinical development requirements
Some packages of diuretic furosemide found to contain sleeping pill zopiclone
BMJ and Channel 4 say access to raw trial data would help resolve uncertainly about GLP-1 agonists
Bad Pharma author says AllTrials and new European legislation make data disclosure unavoidable
Vote backs wider use of GSK's drug in diabetes
Advisory committee to discuss re-analysis of diabetes drug’s safety data
Lundbeck could be the hardest hit with a maximum penalty of €240m
The future of HTA harmonisation in EuropeThe variety and variability of European health technology assessment criteria have created a challenging environment for pharma and a need for much greater harmonisation
India's patents versus India's patientsWhat the Roche Pegasys case means for big pharma
UK Bribery Act: A game changerThe Director of the Serious Fraud Office intends to enforce the Act ‘vigorously’ – it would be wise to take him at his word
EMA backs Pomalidomide Celgene in multiple myelomaFurther positive CHMP opinions for new medicines form Aegerion, Teva and more
GSK/ Valeant's Trobalt set for EU restrictionsEye concerns prompt CHMP to recommend last-line use for the epilepsy drug
EU Parliament panel backs updated clinical trials regulationsBut pharma industry concerned about measures to increase transparency
France ignores EMA and suspends Bayer's Diane 35National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict
India puts cost controls on medicinesDrugs (Prices Control) Order 2013 reduces price of hundreds of drugs
EMA says Bayer's Diane 35 should remain on European marketAgency investigation concludes acne treatment's benefits outweigh its risks
Novo Nordisk: Strict US regulation threatens innovationWarning from CEO Sorensen comes after Tresiba and Ryzodeg fail to win FDA approval
Astellas appoints Dr Songlin Xue head of global pharmacovigilanceHe joins from Takeda and was formerly at Novartis and Wyeth
Agneta Brandt joins EMA as head of infrastructureJoins as company prepares to move offices
GSK's Ellen Strahlman joins med tech firm BDWill serve as the US company's chief medical officer
EMA’s Pharmacovigilance Risk Assessment Committee gains new membersFilip Babylon to represent HCP organisations and Albert van der Zeijden to represent patient organisations
Genzyme’s Richard Moscicki joins FDAProvides regulatory agency with more than 20 years of industry experience
At nitrogen being creative is part of everyone’s role, whether they’re a science writer, account handler or digital ...